UNASSIGNED: Epilepsy, which is associated with neuronal damage and functional decline, typically presents patients with numerous challenges in their daily lives. An early diagnosis plays a crucial role in managing the condition and alleviating the patients\' suffering. Electroencephalogram (EEG)-based approaches are commonly employed for diagnosing epilepsy due to their effectiveness and non-invasiveness. In this study, a classification method is proposed that use fast Fourier Transform (FFT) extraction in conjunction with convolutional neural networks (CNN) and long short-term memory (LSTM) models.
UNASSIGNED: Most methods use traditional frameworks to classify epilepsy, we propose a new approach to this problem by extracting features from the source data and then feeding them into a network for training and recognition. It preprocesses the source data into training and validation data and then uses CNN and LSTM to classify the style of the data.
UNASSIGNED: Upon analyzing a public test dataset, the top-performing features in the fully CNN nested LSTM model for epilepsy classification are FFT features among three types of features. Notably, all conducted experiments yielded high accuracy rates, with values exceeding 96% for accuracy, 93% for sensitivity, and 96% for specificity. These results are further benchmarked against current methodologies, showcasing consistent and robust performance across all trials. Our approach consistently achieves an accuracy rate surpassing 97.00%, with values ranging from 97.95 to 99.83% in individual experiments. Particularly noteworthy is the superior accuracy of our method in the AB versus (vs.) CDE comparison, registering at 99.06%.
UNASSIGNED: Our method exhibits precise classification abilities distinguishing between epileptic and non-epileptic individuals, irrespective of whether the participant\'s eyes are closed or open. Furthermore, our technique shows remarkable performance in effectively categorizing epilepsy type, distinguishing between epileptic ictal and interictal states versus non-epileptic conditions. An inherent advantage of our automated classification approach is its capability to disregard EEG data acquired during states of eye closure or eye-opening. Such innovation holds promise for real-world applications, potentially aiding medical professionals in diagnosing epilepsy more efficiently.

Automatic seizure detection from Electroencephalography (EEG) is of great importance in aiding the diagnosis and treatment of epilepsy due to the advantages of convenience and economy. Existing seizure detection methods are usually patient-specific, the training and testing are carried out on the same patient, limiting their scalability to other patients. To address this issue, we propose a cross-subject seizure detection method via unsupervised domain adaptation. The proposed method aims to obtain seizure specific information through shallow and deep feature alignments. For shallow feature alignment, we use convolutional neural network (CNN) to extract seizure-related features. The distribution gap of the shallow features between different patients is minimized by multi-kernel maximum mean discrepancies (MK-MMD). For deep feature alignment, adversarial learning is utilized. The feature extractor tries to learn feature representations that try to confuse the domain classifier, making the extracted deep features more generalizable to new patients. The performance of our method is evaluated on the CHB-MIT and Siena databases in epoch-based experiments. Additionally, event-based experiments are also conducted on the CHB-MIT dataset. The results validate the feasibility of our method in diminishing the domain disparities among different patients.

UNASSIGNED: Epilepsy is a common neurological condition that affects a large number of individuals worldwide. One of the primary challenges in epilepsy is the accurate and timely detection of seizure. Recently, the graph regularized broad learning system (GBLS) has achieved superior performance improvement with its flat structure and less time-consuming training process compared to deep neural networks. Nevertheless, the number of feature and enhancement nodes in GBLS is predetermined. These node settings are also randomly selected and remain unchanged throughout the training process. The characteristic of randomness is thus more easier to make non-optimal nodes generate, which cannot contribute significantly to solving the optimization problem.
UNASSIGNED: To obtain more optimal nodes for optimization and achieve superior automatic detection performance, we propose a novel broad neural network named self-adaptive evolutionary graph regularized broad learning system (SaE-GBLS). Self-adaptive evolutionary algorithm, which can construct mutation strategies in the strategy pool based on the experience of producing solutions for selecting network parameters, is incorporated into SaE-GBLS model for optimizing the node parameters. The epilepsy seizure is automatic detected by our proposed SaE-GBLS model based on three publicly available EEG datasets and one private clinical EEG dataset.
UNASSIGNED: The experimental results indicate that our suggested strategy has the potential to perform as well as current machine learning approaches.

Seizure is a common neurological disorder that usually manifests itself in recurring seizure, and these seizures can have a serious impact on a person\'s life and health. Therefore, early detection and diagnosis of seizure is crucial. In order to improve the efficiency of early detection and diagnosis of seizure, this paper proposes a new seizure detection method, which is based on discrete wavelet transform (DWT) and multi-channel long- and short-term memory-like spiking neural P (LSTM-SNP) model. First, the signal is decomposed into 5 levels by using DWT transform to obtain the features of the components at different frequencies, and a series of time-frequency features in wavelet coefficients are extracted. Then, these different features are used to train a multi-channel LSTM-SNP model and perform seizure detection. The proposed method achieves a high seizure detection accuracy on the CHB-MIT dataset: 98.25% accuracy, 98.22% specificity and 97.59% sensitivity. This indicates that the proposed epilepsy detection method can show competitive detection performance.

Closed-loop neuromodulation with intelligence methods has shown great potentials in providing novel neuro-technology for treating neurological and psychiatric diseases. Development of brain-machine interactive neuromodulation strategies could lead to breakthroughs in precision and personalized electronic medicine. The neuromodulation research tool integrating artificial intelligent computing and performing neural sensing and stimulation in real-time could accelerate the development of closed-loop neuromodulation strategies and translational research into clinical application. In this study, we developed a brain-machine interactive neuromodulation research tool (BMINT), which has capabilities of neurophysiological signals sensing, computing with mainstream machine learning algorithms and delivering electrical stimulation pulse by pulse in real-time. The BMINT research tool achieved system time delay under 3 ms, and computing capabilities in feasible computation cost, efficient deployment of machine learning algorithms and acceleration process. Intelligent computing framework embedded in the BMINT enable real-time closed-loop neuromodulation developed with mainstream AI ecosystem resources. The BMINT could provide timely contribution to accelerate the translational research of intelligent neuromodulation by integrating neural sensing, edge AI computing and stimulation with AI ecosystems.

OBJECTIVE: Evaluate the performance of a custom application developed for tonic-clonic seizure (TCS) monitoring on a consumer-wearable (Apple Watch) device.
METHODS: Participants with a history of convulsive epileptic seizures were recruited for either Epilepsy Monitoring Unit (EMU) or ambulatory (AMB) monitoring; participants without epilepsy (normal controls [NC]) were also enrolled in the AMB group. Both EMU and AMB participants wore an Apple Watch with a research app that continuously recorded accelerometer and photoplethysmography (PPG) signals, and ran a fixed-and-frozen tonic-clonic seizure detection algorithm during the testing period. This algorithm had been previously developed and validated using a separate training dataset. All EMU convulsive events were validated by video-electroencephalography (video-EEG); AMB events were validated by caregiver reporting and follow-ups. Device performance was characterized and compared to prior monitoring devices through sensitivity, false alarm rate (FAR; false-alarms per 24 h), precision, and detection delay (latency).
RESULTS: The EMU group had 85 participants (4,279 h, 19 TCS from 15 participants) enrolled across four EMUs; the AMB group had 21 participants (13 outpatient, 8 NC, 6,735 h, 10 TCS from 3 participants). All but one AMB participant completed the study. Device performance in the EMU group included a sensitivity of 100 % [95 % confidence interval (CI) 79-100 %]; an FAR of 0.05 [0.02, 0.08] per 24 h; a precision of 68 % [48 %, 83 %]; and a latency of 32.07 s [standard deviation (std) 10.22 s]. The AMB group had a sensitivity of 100 % [66-100 %]; an FAR of 0.13 [0.08, 0.24] per 24 h; a precision of 22 % [11 %, 37 %]; and a latency of 37.38 s [13.24 s]. Notably, a single AMB participant was responsible for 8 of 31 false alarms. The AMB FAR excluding this participant was 0.10 [0.07, 0.14] per 24 h.
CONCLUSIONS: This study demonstrates the practicability of TCS monitoring on a popular consumer wearable (Apple Watch) in daily use for people with epilepsy. The monitoring app had a high sensitivity and a substantially lower FAR than previously reported in both EMU and AMB environments.

Epilepsy is characterized by recurring seizures that result from abnormal electrical activity in the brain. These seizures manifest as various symptoms including muscle contractions and loss of consciousness. The challenging task of detecting epileptic seizures involves classifying electroencephalography (EEG) signals into ictal (seizure) and interictal (non-seizure) classes. This classification is crucial because it distinguishes between the states of seizure and seizure-free periods in patients with epilepsy. Our study presents an innovative approach for detecting seizures and neurological diseases using EEG signals by leveraging graph neural networks. This method effectively addresses EEG data processing challenges. We construct a graph representation of EEG signals by extracting features such as frequency-based, statistical-based, and Daubechies wavelet transform features. This graph representation allows for potential differentiation between seizure and non-seizure signals through visual inspection of the extracted features. To enhance seizure detection accuracy, we employ two models: one combining a graph convolutional network (GCN) with long short-term memory (LSTM) and the other combining a GCN with balanced random forest (BRF). Our experimental results reveal that both models significantly improve seizure detection accuracy, surpassing previous methods. Despite simplifying our approach by reducing channels, our research reveals a consistent performance, showing a significant advancement in neurodegenerative disease detection. Our models accurately identify seizures in EEG signals, underscoring the potential of graph neural networks. The streamlined method not only maintains effectiveness with fewer channels but also offers a visually distinguishable approach for discerning seizure classes. This research opens avenues for EEG analysis, emphasizing the impact of graph representations in advancing our understanding of neurodegenerative diseases.

While many seizure detection methods have demonstrated great accuracy, their training necessitates a substantial volume of labeled data. To address this issue, we propose a novel method for unsupervised seizure anomaly detection called SAnoDDPM, which uses denoising diffusion probabilistic models (DDPM). We designed a novel pipeline that uses a variable lower bound on Markov chains to identify potential values that are unlikely to occur in anomalous data. The model is first trained on normal data, then anomalous data is input to the trained model. The model resamples the anomalous data and converts it to normal data. Finally, the presence of seizures can be determined by comparing the before and after data. Moreover, the input 2D spectrograms are encoded into vector-quantized representations, which enables powerful and efficient DDPM while maintaining its quality. Experimental comparisons on the publicly available datasets, CHB-MIT and TUH, show that our method delivers better results, significantly reduces inference time, and is suitable for deployment in a clinical environments. As far as we are aware, this is the first DDPM-based method for seizure anomaly detection. This novel approach significantly contributes to the progression of seizure detection algorithms, thereby augmenting their practicality in clinical settings.

Wearable devices have attracted significant attention in epilepsy research in recent years for their potential to enhance patient care through improved seizure monitoring and forecasting. This narrative review presents a detailed overview of the current clinical state of the art while addressing how devices that assess autonomic nervous system (ANS) function reflect seizures and central nervous system (CNS) state changes. This includes a description of the interactions between the CNS and the ANS, including physiological and epilepsy-related changes affecting their dynamics. We first discuss technical aspects of measuring autonomic biosignals and considerations for using ANS sensors in clinical practice. We then review recent seizure detection and seizure forecasting studies, highlighting their performance and capability for seizure detection and forecasting using devices measuring ANS biomarkers. Finally, we address the field\'s challenges and provide an outlook for future developments.

UNASSIGNED: Long-term electroencephalography (EEG) monitoring is advised to patients with refractory epilepsy who have a failure of anti-seizure medication and therapy. However, its real-life application is limited mainly due to the use of multiple EEG channels. We proposed a patient-specific deep learning-based single-channel seizure detection approach using the long-term scalp EEG recordings of the Children\'s Hospital Boston-Massachusetts Institute of Technology (CHB-MIT) dataset, in conjunction with neurologists\' confirmation of spatial seizure characteristics of individual patients.
UNASSIGNED: We constructed 18-, 4-, and single-channel seizure detectors for 13 patients. Neurologists selected a specific channel among four channels, two close to the behind-the-ear and two at the forehead for each patient, after reviewing the patient\'s distinctive seizure locations with seizure re-annotation.
UNASSIGNED: Our multi- and single-channel detectors achieved an average sensitivity of 97.05-100%, false alarm rate of 0.22-0.40/h, and latency of 2.1-3.4 s for identification of seizures in continuous EEG recordings. The results demonstrated that seizure detection performance of our single-channel approach was comparable to that of our multi-channel ones.
UNASSIGNED: We suggest that our single-channel approach in conjunction with clinical designation of the most prominent seizure locations has a high potential for wearable seizure detection on long-term EEG recordings for patients with refractory epilepsy.